| Bioactivity | WYC-209, a synthetic retinoid, is a retinoic acid receptor (RAR) agonist. WYC-209 induces apoptosis primarily via the caspase 3 pathway (IC50=0.19 μM for inmalignant murine melanoma TRCs), and has long-term effects with little toxicity[1]. | ||||||||||||
| Invitro | WYC-209 (10 μM; 24 hours) is able to inhibit and block growth of TRCs of human tumor cells in culture with a long-lasting effect[1]. Apoptosis Analysis[1] Cell Line: | ||||||||||||
| Name | WYC-209 | ||||||||||||
| CAS | 2131803-90-0 | ||||||||||||
| Formula | C20H20N2O3S | ||||||||||||
| Molar Mass | 368.45 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
WYC-209
CAS: 2131803-90-0 F: C20H20N2O3S W: 368.45
WYC-209, a synthetic retinoid, is a retinoic acid receptor (RAR) agonist. WYC-209 induces apoptosis primarily via the ca
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.